Table 3.
Inhibitor | Clinically Most Relevant Carbapenemases | |||||||
---|---|---|---|---|---|---|---|---|
KPC-2 | IMP-1 | VIM-1 | NDM-1 | OXA-23 | OXA-24/40 | OXA-48 | ||
Diazabicyclooctane-derived | ||||||||
Avibactam | IC50 (nM) | 170 [30] */22 [31]/60 [32] | >1.6 × 105 [31]/>1.0 × 105 [32] | >1.6 × 105 [31] | >1.6 × 105 [31]/>1.0 × 105 [32] | 3.1 × 103 [31]/8.9 × 103 [33] | 1.60 × 104 [30]/2.23 × 104 [33] | 180 [31]/550 [32] |
Kiapp (nM) | 900 [34]/11 [35] | >4.0 × 104 [35] | >4.0 × 104 [35] | >4.0 × 104 [35] | >1.0 × 105 [34]/1.7 × 103 [35] | >1.0 × 105 [34]/1.54 × 105 [33] | 3.0 × 104 [34]/27 [35] | |
Relebactam | IC50 (nM) | 82 [31]/230 [36] | >1.6 × 105 [31] | >1.6 × 105 [31] | >1.6 × 105 [31] | 9 × 104 [31] | ||
Kiapp (nM) | 2.2 × 103 [34]/1.2 × 103 [36] | >1.0 × 105 [34] | >1.0 × 105 [34] | >1.0 × 105 [34] | ||||
Zidebactam | IC50 (nM) | |||||||
Kiapp (nM) | 4.5 × 103 [34] | >1.00 × 105 (VIM-2) [37] | >1.0 × 105 [34] | >1.0 × 105 [34] | >1.0 × 105 [34] | |||
Durlobactam | IC50 (nM) | 4 [30] | 190 [30] | |||||
Kiapp (nM) | ||||||||
Nacubactam | IC50 (nM) | 869 [38] | >3.0 × 105 [38] | 4.64 × 104 [38] | ||||
Kiapp (nM) | 3.1 × 104 [39] | |||||||
ETX1317 | IC50 (nM) | 43 [40] | 540 [40] | 77 [40] | ||||
Kiapp (nM) | ||||||||
WCK 4234 | IC50 (nM) | |||||||
Kiapp (nM) | 320 [34] | 8.0 × 103 [34] | 5.0 × 103 [34] | 290 [34] | ||||
Boronic acid-derived | ||||||||
Vaborbactam | IC50 (nM) | 110 [31]/100 [32] | >1.6 × 105 [31]/>1.0 × 105 [32] | >1.6 × 105 [31] | >1.6 × 105 [31]/>1.0 × 105 [32] | 1.2 × 105 [31] | 6.9 × 103 [31]/3.88 × 104 [32] | |
Kiapp (nM) | 22 [41]/56 [35] | >3.0 × 104 [41]/>4.0 × 104 [35] | >4.0 × 104 [35] | >3.0 × 104 [41]/>4.0 × 104 [35] | >4.0 × 104 [35] | 350 [41]/1.4 × 104 [35] | ||
Taniborbactam | IC50 (nM) | 30 [32] | 2.51 × 103 [42]/3.98 × 104 [32] | 7.9 [42] | 10 [42]/190 [32] | 537 [42]/420 [32] | ||
Kiapp (nM) | 4 [41] | >3.0 × 104 [41] | 19 (VIM-2) [41] | 81 [41] | 350 [41] | |||
VNRX-5236 | IC50 (nM) | 80 [43] | >1.0 × 105 [43] | 9.04 × 103 (VIM-2) [43] | 3.81 × 104 [43] | 317 [43] | ||
Kiapp (nM) | 110 [43] | |||||||
QPX7728 | IC50 (nM) | 2.9 [31] | 610 [31] | 14 [31] | 55 [31] | 1.2 [31] | 1.1 [31] | |
Kiapp (nM) | 1.9 [35] | 220 [35] | 8 [35] | 32 [35] | 0.74 [35] | 0.28 [35] | ||
β-lactam-derived | ||||||||
Enmetazobactam | IC50 (nM) | 360 a [44] | 1.1 × 104 a [44] | |||||
Kiapp (nM) | ||||||||
LN-1-255 | IC50 (nM) | 12 [33] | 15 [33] | 3 [45] | ||||
Kiapp (nM) | 88 [33] | 289 [33] | 170 [45] | |||||
Pyridine-2-carboxylic acid | ||||||||
ANT2681 | IC50 (nM) | |||||||
Kiapp (nM) | 3.81 × 103 [46] | 630 [46] | 40 [46] |
a Assays performed with bacterial extracts, not purified enzyme. * Numbers in brackets corresponde with references.